Showing results (511-520 of 665) with videos related to
Sort By:
Pageof 67
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 7, 2001
The utility of (18)F-FDG PET for suspected recurrent non-small cell lung cancer after potentially curative therapy: impact on management and prognostic stratificationR J Hicks, V Kalff, M P MacManus, et al.British Journal of Haematology|April 1, 1996
Association of acquired Pelger-Huet anomaly with taxoid therapyS K Juneja, J P Matthews, R Luzinat, et al.Clinical Pharmacology and Therapeutics|June 13, 2023
Considerations for Cell and Gene Therapy Programs Entering the Clinical SpaceGeoffrey A Walford, An Bautmans, Carol Cannon, et al.Antimicrobial Agents and Chemotherapy|November 21, 2018
Population Pharmacokinetics and Pharmacodynamics of Bezlotoxumab in Adults with Primary and Recurrent Clostridium difficile InfectionKa Lai Yee, Huub Jan Kleijn, Thomas Kerbusch, et al.Antimicrobial Agents and Chemotherapy|March 5, 2025
Pharmacokinetics of islatravir in participants with moderate hepatic impairmentRandolph P Matthews, Munjal Patel, Wen Liu, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1994
A randomised double blind crossover study of domperidone and prochlorperazine suppositories for controlling emesis in outpatients receiving chemotherapyI N Olver, C R Laidlaw, J P Matthews, et al.Physical Chemistry Chemical Physics : PCCP|March 19, 2015
An OHD-RIKES and simulation study comparing a benzylmethylimidazolium ionic liquid with an equimolar mixture of dimethylimidazolium and benzeneLianjie Xue, George Tamas, Richard P Matthews, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 29, 2003
Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancerMichael P Mac Manus, Rodney J Hicks, Jane P Matthews, et al.Head & Neck|October 2, 2004
Usefulness of fluorine-18 fluorodeoxyglucose positron emission tomography in patients with a residual structural abnormality after definitive treatment for squamous cell carcinoma of the head and neckRobert E Ware, Jane P Matthews, Rodney J Hicks, et al.Leukemia & Lymphoma|July 31, 1998
Prognostic markers of disease activity in Hodgkin's diseaseA J Martinow, K Yuen, I A Cooper, et al.Pageof 67